Spinal cord ependymoma, MYCN-amplified

View Details
Status
Done

Definition

  • Essential:
    • Spinal tumour with morphological and immunohistochemical features of ependymoma AND
    • MYCN amplification
  • Desirable:
    • DNA methylation profile aligned with spinal ependymoma, MYCN-amplified
    • High-grade histopathological features

Numbers

  • Rare type < 30 cases reported in the literature
  • Median age of presentation 31 years
  • Female predilection

Genetic

  • MYCN. a member of the MYC family of proto-oncogenes encodes transcription factor that regulates the expression of genes involved in cell growth

Location

  • Often (78% of cases) in the cervical or thoracic cord

Grade ?

  • Awaiting grading from WHO
  • High-grade histopathological features
  • Poor prognosis

Pathology

  • A well-demarcated tumour

Radiology

  • Tumours tend to be large with cord infiltration spanning multiple vertebral levels.
  • Primarily intramedullary and nodular extramedullary presentations have been reported, and diffuse leptomeningeal disease is typical
  • MRI
    • T1: most are isointense to hypointense;
      • Mixed-signal lesions are seen if cyst formation, tumour necrosis or haemorrhage has occurred
    • T2: hyperintense
      • Peritumoural oedema is seen in 60% of cases
      • Associated haemorrhage leads to the “cap sign” (a hypointense haemosiderin rim on T2 weighted images) in 20-33% of cases 5. The cap sign is suggestive of but not pathognomonic for ependymoma as it may also be seen in haemangioblastomas and paragangliomas
    • T1 C+ (Gd): virtually all enhance strongly, somewhat inhomogeneously

Prognosis

  • This tumour is aggressive with all reported patients suffering disease recurrence at follow-up despite intensive treatment
  • Early metastasis